5-(tert-Butoxycarbonyl)octahydrofuro[3,2-c]pyridine-7-carboxylic acid, 98+%, 500mg

(2-Methylthiazol-5-yl)methanol, 95.0%, 5g

N-Carbobenzoxy-DL-methionine>98.0%(HPLC)(T)10g

(1S,2S)-2-(trifluoromethyl)cyclobutan-1-amine hydrochloride, 98%, 1g

1-Tritylpiperidin-4-one, 95.0%, 5g

5-Bromo-N,N-dimethylpyrazin-2-amine, 95.0%, 250mg

4-Fluoropiperidine hydrochloride, 97.0%, 1g

(S,R,S)-AHPC-PEG4-NH2 hydrochloride, 1g

tert-Butyl 4-(2-hydroxyethyl)piperazine-1-carboxylate, 95.0%, 10g

2-Bromo-3-methoxyaniline, 95.0%, 5g

(2S,3S,5R,6R)-5,6-Bis(azidomethyl)-2,3-dimethoxy-2,3-dimethyl-1,4-dioxane>97.0%(GC)100mg

Colonne capillaire GC ROTI®Cap-1, 30 m, 0,25 mm, 0,25 µm, 1 pièce(s)

2-(3-Amino-phenyl)-benzothiazol-6-ylamine, 98%, 1g